Booster doses of the original monovalent COVID-19 vaccine are associated with lower incidence of symptoms in health care personnel 6 weeks postinfection.

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Background: The safety and immunogenicity of Viatim, a combined hepatitis A (HA) and typhoid fever (Vi) vaccine, were compared with the monovalent component vaccines up to and 1 month after a ...

Unlike previous vaccines, the updated COVID-19 vaccines are monovalent, which means the vaccines only provide protection against the most recent strain of COVID-19. Rebecca Wurtz, health policy ...

Genital Chlamydia trachomatis infection is a significant public health burden; Professor of Pediatrics and Microbiology and ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

The chair of the national vaccination committee on the latest vaccine developments and the importance for vulnerable groups ...

In a related JAMA Viewpoint, the authors noted that COVID-19 peaked in 2020 and 2021 as the third highest cause of mortality ...

However, BioNTech continues to innovate, with an omicron-targeting bivalent vaccine launched in 2022 and a new XBB-targeting monovalent vaccine launched in September 2023, as well as ongoing ...